|
|
| Chairman Speak |
|
Dear Guest,
We take great pride in what we do at Hiran and our employees above all are entitled to that pride, because they make it possible for us to achieve what we have. A workforce having the expertise, intellect, dedication and spirit to succeed, along with a collective organizational commitment to deliver continued growth and profitability for shareholders bodes very well for our future.
Our Business Philosophy is based on constantly delivering value to our stakeholders and customers which inspire people to innovate, achieve excellence and set new global benchmarks. Driven by our vision to become a global leader we reinvent our self time and again to achieve sustained growth and leadership.
We started with our Main product Ciprofloxacin in 1992 with production of 3 MT per month. Today we produce 3 MT every day. Being our main product, we intend to achieve leadership globally. We have also been successful in launching many products over the years. Today, we are one of the largest manufacturers of Quinolones group of API's like Ciprofloxacin, Enrofloxacin, Ofloxacin, Levofloxacin, etc.
We intend to diversify in other products which are under development, and we intend to launch 20 API's in next two years with large production capacities. At Hiran, we view our R&D capabilities as a vital component of our business strategy as that will provide us sustainable and long term competitive advantage. Continuous R&D efforts are on to formulate new products conforming to International standards.
With Pharmaceutical business being our main sector, we have also diversified into Real Estate Business. Though our plans are still at a very nascent stage we have forayed into the Real Estate business by announcing plans of building integrated townships.
We are thankful to all our shareholders, customers, employees and well wishers for their continuous support to convert our plans into successful ventures.
Warm Personal Regards,
|
| Kantilal Hiran |
| Chairman & Managing Director |
| Hiran Orgochem Ltd. |
|
|
| |
